Advances and Challenges in Radiation Protection of Patients Modern Radiotherapy. Risk Acceptability

Similar documents
AllinaHealthSystems 1

PROSTATE CANCER CONTENT CREATED BY. Learn more at

Prostate Cancer Incidence

NICE BULLETIN Diagnosis & treatment of prostate cancer

THE UROLOGY GROUP

Newer Aspects of Prostate Cancer Underwriting

16:30-18:30 WS #67: Urology Forum - Prostate Cancer, Stones, Renal Tumours, Voiding Dysfunction (120 minutes, not repeated) -

The Prostate Cancer Surgery Tick List. Use these questions as starters for your first meeting with your prostate cancer surgeon.

What Is Prostate Cancer? Prostate cancer is the development of cancer cells in the prostate gland (a gland that produces fluid for semen).

Community care of Prostate Cancer. Shaun Costello Southern Cancer Network

18-Oct-16. Take home messages. An update for GPs on modern radiation therapy & hormones for prostate cancer. Session plan

Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer

Navigating the Stream: Prostate Cancer and Early Detection. Ifeanyi Ani, M.D. TPMG Urology Newport News

When to worry, when to test?

Prostate Cancer: 2010 Guidelines Update

Treating Prostate Cancer

Outcomes With "Watchful Waiting" in Prostate Cancer in US Now So Good, Active Treatment May Not Be Better

Causes of Raised PSA A very large prostate Gland Infection of urine or Prostate Gland Possibility of prostate Cancer

Helping you make better-informed decisions 1-5

TOOKAD (padeliporfin) Patient Information Guide

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director

Technological Advances in Radiotherapy for the Treatment of Localized Prostate Cancer - A Systematic Review

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

Prostate Biopsy. Prostate Biopsy. We canʼt go backwards: Screening has helped!

Chapter 18: Glossary

An educational guide from Genomic Health

Prostatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London

Area offers new approach to detecting, diagnosing and treating prostate cancer. by ANDREA GABLE

General information about prostate cancer

3/6/2018 PROSTATE CANCER IN 2018 OBJECTIVE WHAT IS THE PROSTATE? WHAT DOES IT DO? Rahul Mehan, MD

Irreversible Electroporation for the Treatment of Recurrent Prostate Cancer

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

The Center for Prostate Care, ProHealth Care Regional Cancer Center, Wisconsin

Men s Health Topics. Jerome Baca, MS, PA-C. Albuquerque Urology Associates January 6 th, 2018

Prostate Cancer Treatment

Prostate Cancer Treatment Experts

PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT

Cancer Endorsement Maintenance 2011-Maintenance Measures

Your Guide to Prostate Cancer

MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT

Active Surveillance for Prostate Cancer

NCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer Webinar #4: NCRA /2/17 Eileen Tonner, MS

2008_Prostate_Awareness 12/22/08 1:47 PM Page 1

The Changing Landscape of Prostate Cancer

BIOCHEMICAL RECURRENCE POST RADICAL PROSTATECTOMY

da Vinci Prostatectomy

Taking Control of Your Destiny... Douglas P. Menelly

Prostate Cancer in men with germline DNA repair deficiency

Prostate cancer: intervention comparisons

Prostate Cancer UK Best Practice Pathway: ACTIVE SURVEILLANCE

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for

PET imaging of cancer metabolism is commonly performed with F18

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

Prostate Cancer Case Study 1. Medical Student Case-Based Learning

Prostate Cancer. What is prostate cancer?

Prostatic Cryosurgery and Robotic Prostatectomy

Prostate Cancer UK s Best Practice Pathway

Managing Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps?

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS

Prostate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC

PCSANM 2015 Seminar. Basic Knowledge: Test for Prostate Cancer. Jerry Cross. 15 item quiz, no grades given

PSA nadir post LDR Brachytherapy and early Salvage Therapy. Dr Duncan McLaren UK & Ireland Users Group Meeting 2016

Prostate Cancer: from Beginning to End

Effective Health Care Program

NCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer. Project Overview Ronald C. Chen, MD MPH

Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate

2011 PROSTATE BRACHYTHERAPY STUDY

[PDF] ALTERNATIVES TO LUPRON FOR PROSTATE CANCER EBOOK

Prostate Overview Quiz

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER

Economic Model of Multiple Radiation Therapy Treatments for Low-Risk Prostate Cancer: Overview. June 4, Julia Hayes, M.D. Pamela McMahon, Ph.D.

Prostate Cancer Awareness - Prevention, Symptoms and. Treatment

Brachytherapy for Prostate Cancer

Deciding on treatment: a step on your journey.

Comparing Radiation Treatments for Prostate Cancer: What Does the Evidence Tell Us?

Prostate Cancer Treatment Decision Information Background

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

Screening for Disease

Radical prostate surgery?

OHTAC Recommendation

Definition Prostate cancer

PROSTATE CANCER: A Primer of Diagnosis and Treatment. Jay C. Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Prostate Cancer. David Wilkinson MD Gulfshore Urology

PROSTATE CANCER Amit Gupta MD MPH

Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement

The clinical and cost effectiveness of the use of brachytherapy to treat localised prostate cancer Health technology description

Cryotherapy for recurrent prostate cancer. Issue date: May 2005

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

LESSON 5.2 WORKBOOK. What do cancer screens really tell us? Workbook Lesson 5.2

c) Do you think radiation treatment for my cancer is better than surgically removing my gland, and if so, why?

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

Prostate Cancer Dashboard

PSA Screening and Prostate Cancer. Rishi Modh, MD

Prostate Cancer Treatments. Hasan Murshed, MD., DABR Radiation Oncology Residency, UAB Fellowship, MDACC Board Certified, ABR

Localized Prostate Cancer and Its Treatment- A Patient Guide

Best Papers. F. Fusco

f) DATTOLI CANCER CENTER

Comparative Analysis Research of Robotic Assisted Laparoscopic Prostatectomy

Transcription:

Advances and Challenges in Radiation Protection of Patients Modern Radiotherapy Risk Acceptability Versailles, France December 2-4, 2009 Fred A. Mettler Jr. M.,D., M.P.H. New Mexico Federal Regional Medical Center Albuquerque, New Mexico, USA

Radiation Protection in Medicine ICRP 105 says.. Justification.. Use of radiation in medicine (level1) of a practice/procedure (level 2) for an individual (level 3) Benefit should exceed risk Optimization of the relationship between tumor control and complications..but there is little guidance on how risk/benefit balance is to be done in medicine or who actually does it

Risk Is risk really quantifiable? While many dangers are quantifiable. judgments, values and culture affect acceptability of risk A basic difficulty is that those should or will participate in the risk decision have divergent perspectives Radiation risk and acceptability cannot be dealt with alone. They occur in a world with many other factors

Quantitative risk assessment (QRA): Can we do it for cancer therapy? What can go wrong with our system? What is the likelihood of that happening under the current plan? If it does happen what are the consequences? i.e. what is the damage?

Can we find an extreme example of radiation and other risks.. to look at how risk acceptability is done?

The radiation protection philosophy and risk acceptability views of an astronaut Ellen Baker, NASA As astronauts our mission risks are high but that does not mean that we should also accept high levels of radiation risk We still do not understand the full range of radiation risks Therefore we rely on you to provide us with the latest information and provide us with the most up-to-date techniques to reduce or minimize radiation risks

What is the universe of risk the patient is faced with? A tour of risk through the patients eyes Prostate cancer as an example most common cancer in men

Risk acceptance in radiotherapy Who accepts the risk???? The patient.. Isn t that obvious??

Can we really expect any normal 70-year old figure out whether to accept the risks and uncertainties that are associated with prostate cancer? Occult tumors Clinical staging PSA screening Cryosurgery Biopsy PSA velocity Impotence Gleason score Watchful waiting Biochemical recurrence IMRT Bone scan/ct/mri Brachytherapy Hormone therapy Radical prostatectomy Survival rate Conformal radiotherapy Robotic surgery

The risk/decision pathways for the prostate cancer patient PSA Screen no yes RPP PSA < 4 <4 but rising >4 no Biopsy yes Gleason 6 or less 7 8,9 Staging Clinical no Bone scan/ct/mri yes Robotic External Brachytherapy Both Surgery Radiation? negative equivocal positive no Hormone yes

PSA Screen no yes RPP Biopsy yes Gleason 7 8,9 Robotic Risk of anywhere from 15-30% Surgery of being wrong about whether he has cancer at all and it may not make External much difference in outcome Radiation Brachytherapy? Both Percent of patients with PSA < 4 with cancer ~15% Percent of patients with PSA > 4 without cancer ~ 65-75% no PSA screening doubles the 6 incidence or less of diagnosis does not change death rate (NEJM 360: 1310-1319,2009) negative no Bone scan/ct/mri yes equivocal positive Staging Clinical yes Hormone no

Can PSA or Gleason score determine bone metastases or disease extent? PSA <10 10-20 20-50 >50 1.7% 5.9% 11.5% 53.3% Gleason score A score of 7 or greater has a 58% accuracy regarding disease confined to the prostate this criteria has a 42% chance of being wrong

What are results of bone scans? Staging 9% positive 9% equivocal 82% negative Or ~10% of the time we say we don t know whether you have metastatic disease or which therapy is appropriate Followup - 18% positive - 9% equivocal -73% negative

How accurate are the bones scan interpretations?

NaF-18 PET/CT bone scan

NaF-18 PET/CT bone scan

More NaF-18 scans read as equivocal but 8/8 biopsies were negative for malignancy..

How accurate is the clinical staging by the physician? Subsequent surgery has shown that about 50% of the time, clinical staging underestimates the spread of disease Or a risk of 50% error if you only rely on your doctors physical examination

Which therapy should I have?

Risk Perception and communication What you said was not necessarily what you meant and What you said was not necessarily what he heard

How the same risk data presented differently affects choice Mortality rate Survival rate Surgery Radiation Surgery Radiation Treatment 10% 0% 90% 100% After 1 yr 32% 23% 68% 77% After 5 yr 66% 78% 34% 22% % choosing RT 44% 18% McNeil NEJM 306 1259-1262,1982 assumed lung cancer

Where is the data on which therapies work best? I will ask Dr. Google...

da Vinci robotic therapy ad

Surgery has a better cure rate than brachytherapy

Brachytherapy possibly combined with external is almost as good as surgery and with fewer complications

OK, I ve confused myself enough on all the other issues and I have now decided to do radiation therapy what are my risks from that??

Prostate radiotherapy complications External Urinary grade 3 or more 8% GI toxicity grade 3 or more 3-4% Brachytherapy 21% nocturia 12% need β blockers 8-9% erectile dysfunction 6% incontinence 5% rectal injury 3-8% catheter dependent or need surgery

What is the radiotherapy accident risk? In the U.S. annually 197,000 patients get external beam radiotherapy for prostate cancer and ~50,000 get brachytherapy

92 of 116 cases under-treated

What is the second cancer risk from prostate radiotherapy? Depending on what you read Pick a number between 0 and 25%

2007 Literature review from mid 1980 to 2007..after age adjustment no clear increase was detectable 0% risk

2008 The age adjusted rate of SPC for external beam was 2.45/100,000 The hazard ratio for SPC was 1.26 for external beam compared to no radiotherapy (26% increase) No significant differences were seen in the incidence of radiation-induced second primary cancers between the radiation therapy groups

2007 approximately one in 70 patients undergoing radiation and surviving more than 10 years will develop secondary cancer.or 1.4% not necessarily due to radiation

2009 external Overall incidence of SPC was 8.4% 1747 cases / 100,000 for surgery and radiotherapy 1581 cases/ 100,000 for surgery only..an excess of 374 cases/100,000 was seen in the external radiotherapy group compared to surgery or 0.4% excess risk

Even what risk is accepted by the patient does not occur in a void Family Age Quality of life Co-morbidities Financial Availability Trust in physician

A large part of risk acceptance is not really done by the patient at all But by Patient Family Physician Institution Manufacturers Regulators Society

What I would ask Has the machine been fixed lately? What are the qualifications of the staff? Are there recent changes in staff? What are the data on cure and complication nationally compared to this hospital? During my treatment, how do you check what dose I am getting or have gotten? How long has this particular machine and protocol been used?

My conclusions The patient does not really understand all the risks in a complex situation and therefore cannot fully accept the risk The techniques and treatments change rapidly and risk is often not well defined so physicians cannot fully explain the risks Many risks are determined (accepted) by manufacturers, advisory and regulatory bodies who have made decisions

My conclusions Radiation risks are not the major issue faced by the patient. There are many other larger risks and unknowns the patient must deal with. Radiation risks are essentially controlled (accepted) by persons other than the patient Risk acceptance largely depends on the trust in the institutions presenting the expert rating and by the previous success and failures of those institutions. (Short 1984)

Philosophy of protection (astronaut) patient As (astronauts) patients our (mission) risks are high but that does not mean that we should also accept high levels of radiation risk We still do not understand the full range of radiation risks Therefore we rely on you to provide us with the latest information and provide us with the most up-to-date techniques to reduce or minimize radiation risks

Does it work that way all the time??

Thank you